29 November 2019

Gijs Overheul, Pascal Miesen and Ronald van Rij, dept. of Medical Microbiology, theme Infectious diseases and global health, have elucidated the mechanism by which a DNA virus evades small RNA-based immunity of the host. They have published their results in PNAS.

Host immunity exerts strong selection pressure on viruses, often leading to the evolution of viral mechanisms to evade or suppress the immune response. It is well established that RNA interference (RNAi) is a potent antiviral immune system against RNA viruses. As a counter-defense, RNA viruses often encode proteins that suppress the RNAi response. RNAi also targets DNA viruses, but the antiviral effects seem to be modest.

Using the fruit fly Drosophila melanogaster and a large DNA virus of insects (IIV6) as model system, the research group of Van Rij, including former PhD candidates Walter Bronkhorst and Rob Vogels, has studied the complex interactions between virus and host RNAi. The researchers now show that wildtype IIV6 is indeed mostly insensitive to RNAi, but that an IIV6 mutant lacking its RNAi antagonistic protein becomes extremely sensitive to RNAi. Thus, RNAi is in fact strongly antiviral against DNA viruses, but virus-encoded immune antagonists can fully mask this antiviral activity.

On the photo, from left to right: Ronald van Rij, Gijs Overheul, Pascal Miesen
 

Related news items


650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more

ERC Proof of Concept grant received by Ronald van Rij

30 July 2020

Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.

read more

Hypatia fellowship Call is open

30 July 2020

The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.  

read more

Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation. 

29 July 2020

These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.

read more

Genetic mutation reveals how coronavirus strikes TLR7 plays essential role in disease process

28 July 2020

''Does a congenital immune defect play an important role in the defense against Coronavirus?'' This was published by Cas van der Made, Frank van der Veerdonk and Alexander Hoischen.

read more